Boehringer Ingelheim: Christine Sakdalan and Mike Jablonski talk precision psychiatry

Power to the Patients

Apr 09 2025 | 00:40:32

00:00 / 00:40:32

Show Notes

In this episode of Power to the Patients, Boehringer Ingelheim leaders Christine Sakdalan and Mike Jablonski from discuss how precision psychiatry—using tools like biomarkers and neuroimaging—can personalize treatment for conditions like schizophrenia and depression. They highlight the importance of holistic care, digital therapeutics, and industry collaboration to address unmet needs and improve outcomes in mental health.

Other Episodes

Episode

September 27, 2023 • 00:40:32

Patient-centered design with Scott Schliebner, former SVP at ICON

In this episode, Scott Schliebner, a life sciences and digital health executive with experience across the biopharma, CRO, medtech, and non-profit sectors, discusses the...

Episode

December 27, 2023 • 00:43:13

Patient-first Approaches in Clinical Trials with Megan Liles

Explore the world of clinical trials with our guest, Megan Liles. Drawing from her 25+ years of experience, Megan offers a practical perspective on...

Episode 9

January 21, 2025 • 00:48:48

Breaking New Ground with Psilocybin

In this episode, Brandon Li speaks with Kabir Nath, CEO of Compass Pathways, about their groundbreaking work in using psilocybin for treatment-resistant depression (TRD)....